The Journal of clinical psychiatryDec 10, 1999

Comparing once-daily extended-release venlafaxine and fluoxetine in outpatients with depression and anxiety

Psychedelic Science Weekly Brief ↗PubMed ↗DOI ↗

Updated Apr 3, 2026

Weekly Psychedelic Science Brief

You found one interesting study. We’ll send the next 7.

Get 7 new psychedelic science papers each week, explained in plain English with direct links to the originals.

What Lands in Your Inbox Each Week:

📚7 fresh studies
📝plain-language summaries
✅direct links to original studies
🏅top journal indicators
📅weekly delivery
🧘‍♂️always free

Recent issues from the psychedelic science brief

Psilocybin stays active in neurons long after it leaves the bloodstream — here's what that means

2 days ago7 studies

Psychedelics during adolescence reshaped adult social behavior in rats — here's the circuit

1 week ago7 studies

Psilocybin rewired prefrontal circuits in mice — but only for one specific type of cognitive failure

2 weeks ago7 studies

Psilocybin cut two specific brain chemicals in depressed patients — here's what that means

3 weeks ago7 studies

Psilocybin rewires brain feedback circuits for weeks after a single dose, new evidence shows

4 weeks ago7 studies

A pill form of ketamine cut dissociation to near-zero vs. nasal spray's 29.6-point spike — but missed its main antidepressant target

5 weeks ago7 studies

At-home ketamine injections cut depression scores by more than half in 3,870 patients

6 weeks ago8 studies

Psychedelics disrupt brain signal flow in both humans and mice across LSD, psilocybin, and MDMA

7 weeks ago7 studies

Inhaled 5-MeO-DMT cut postpartum depression scores by 35 points

8 weeks ago7 studies

Psilocybin's antidepressant effects lasted 12 months in 126 treatment-resistant patients

9 weeks ago7 studies

explore the archive

See more issues from the psychedelic science brief